NovaBay Pharmaceuticals, Inc. (NBY)

2.26 +0.45 (+24.86%) USD  |  NYAM  |  Dec 10, 13:30
More

NovaBay Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for NBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Palatin Technologies, Inc. --
Theriva Biologics, Inc. --
Oragenics, Inc. --
NanoViricides, Inc. --
Actinium Pharmaceuticals, Inc. --